Mansbach Harry H has filed 39 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 50000 shares of 89bio, Inc. ($ETNB) on October 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 352,656.0000 | 157,880,203 | 16.52% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 320000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.20% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 195000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.12% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 120000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.08% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 67500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 39037 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 98204 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.06% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | U | Common Stock | 352656 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.22% |
| Aug. 1, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 7680 | $9.16 | 302,656.0000 | 157,880,203 | 2.47% | 0.00% |
| June 12, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 8498 | $9.62 | 310,336.0000 | 104,714,613 | 2.67% | 0.01% |
| Feb. 17, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1050 | $10.57 | 318,834.0000 | 104,714,613 | 0.33% | 0.00% |
| Feb. 9, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3817 | $11.41 | 319,884.0000 | 104,714,613 | 1.18% | 0.00% |
| Feb. 1, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 104,714,613 | 9999.99% | 0.31% |
| Feb. 1, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 80000 | $0.00 | 327,039.0000 | 104,714,613 | 32.38% | 0.08% |
| Feb. 1, 2025 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3338 | $9.60 | 323,701.0000 | 104,714,613 | 1.02% | 0.00% |
| Dec. 12, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 95000 | $0.00 | 247,039.0000 | 99,831,111 | 27.77% | 0.10% |
| Sept. 9, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 5352 | $8.46 | 152,039.0000 | 99,831,111 | 3.40% | 0.01% |
| Aug. 17, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1046 | $8.04 | 157,391.0000 | 99,831,111 | 0.66% | 0.00% |
| Feb. 17, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1046 | $9.74 | 158,437.0000 | 71,172,870 | 0.66% | 0.00% |
| Feb. 9, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3568 | $8.45 | 159,483.0000 | 71,172,870 | 2.19% | 0.01% |
| Feb. 5, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1190 | $9.80 | 163,051.0000 | 71,172,870 | 0.72% | 0.00% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 48750 | $0.00 | 164,241.0000 | 71,172,870 | 42.21% | 0.07% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 71,172,870 | 9999.99% | 0.27% |
| Jan. 5, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 9671 | $11.53 | 115,491.0000 | 71,172,870 | 7.73% | 0.01% |
| Jan. 5, 2024 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 25000 | $0.00 | 125,162.0000 | 71,172,870 | 24.96% | 0.04% |
| Sept. 9, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3821 | $16.61 | 100,162.0000 | 34,806,349 | 3.67% | 0.01% |
| Aug. 1, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 577 | $15.64 | 104,997.0000 | 34,806,349 | 0.55% | 0.00% |
| Aug. 17, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1014 | $15.46 | 103,983.0000 | 34,806,349 | 0.97% | 0.00% |
| June 30, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 8334 | $0.00 | 108,456.0000 | 34,806,349 | 8.32% | 0.02% |
| June 30, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2882 | $18.95 | 105,574.0000 | 34,806,349 | 2.66% | 0.01% |
| March 31, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 8333 | $0.00 | 103,004.0000 | 34,806,349 | 8.80% | 0.02% |
| March 31, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2882 | $15.23 | 100,122.0000 | 34,806,349 | 2.80% | 0.01% |
| Feb. 17, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2127 | $13.97 | 94,671.0000 | 34,806,349 | 2.20% | 0.01% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 30000 | $0.00 | 96,798.0000 | 34,806,349 | 44.91% | 0.09% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 34,806,349 | 9999.99% | 0.34% |
| Feb. 5, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1360 | $13.24 | 66,798.0000 | 34,806,349 | 2.00% | 0.00% |
| Feb. 1, 2023 | 89bio, Inc. | $ETNB | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 680 | $12.05 | 68,158.0000 | 34,806,349 | 0.99% | 0.00% |